Literature DB >> 20411782

Inflammatory response in Parkinsonism.

Carlos Barcia1, Francisco Ros, María Angeles Carrillo, David Aguado-Llera, Carmen María Ros, Aurora Gómez, Cristina Nombela, Vicente de Pablos, Emiliano Fernández-Villalba, Maria-Trinidad Herrero.   

Abstract

Inflammatory responses have been proposed as important factors in dopaminergic neuro-degeneration in Parkinsonism. Increasing evidence suggests that the alteration of the glial microenvironment induced by neuronal degeneration could be deleterious to the remaining neurons. The activation of microglia/macrophages and reactive astrocytes may have a negative effect on the surrounding parenchyma, perpetuating the neurodegenerative process. However, this alteration may also go beyond the brain parenchyma and stimulate other inflammatory changes in other systems, inducing the release of proinflammatory cytokines and probably Acute Phase Proteins (APP) and Glucocorticoids (GC). In this work we review the latest advances in the field to provide a picture of the state of the art of studies of inflammatory responses and Parkinsonism, hopefully opening up new therapeutic perspectives for patients with Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20411782     DOI: 10.1007/978-3-211-92660-4_19

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  6 in total

1.  Morphine modulation of toll-like receptors in microglial cells potentiates neuropathogenesis in a HIV-1 model of coinfection with pneumococcal pneumoniae.

Authors:  Raini Dutta; Anitha Krishnan; Jingjing Meng; Subash Das; Jing Ma; Santanu Banerjee; Jinghua Wang; Richard Charboneau; Om Prakash; Roderick A Barke; Sabita Roy
Journal:  J Neurosci       Date:  2012-07-18       Impact factor: 6.167

2.  Potent suppression of arginase 1 expression in murine macrophages by low dose endotoxin.

Authors:  Michael J Surace; Liwu Li
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

3.  A 5-Year Follow-up Study on the Relationship between Obstructive Sleep Apnea and Parkinson Disease.

Authors:  Jau-Jiuan Sheu; Hsin-Chien Lee; Herng-Ching Lin; Li-Ting Kao; Shiu-Dong Chung
Journal:  J Clin Sleep Med       Date:  2015-12-15       Impact factor: 4.062

Review 4.  Estrogen receptor β and Liver X receptor β: biology and therapeutic potential in CNS diseases.

Authors:  M Warner; J-A Gustafsson
Journal:  Mol Psychiatry       Date:  2014-03-25       Impact factor: 15.992

Review 5.  Glial-mediated inflammation underlying parkinsonism.

Authors:  Carlos Barcia
Journal:  Scientifica (Cairo)       Date:  2013-07-11

6.  Rhes Counteracts Dopamine Neuron Degeneration and Neuroinflammation Depending on Gender and Age.

Authors:  Giulia Costa; Annalisa Pinna; Pier Francesca Porceddu; Maria Antonietta Casu; Anna Di Maio; Francesco Napolitano; Alessandro Usiello; Micaela Morelli
Journal:  Front Aging Neurosci       Date:  2018-05-31       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.